Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v8-FR
Language French French
Date Updated 2024-02-23 2024-02-23
Drug Identification Number 00839183 00839183
Brand name APO-DICLO APO-DICLO
Common or Proper name DICLOFENAC NA DICLOFENAC NA
Company Name APOTEX INC APOTEX INC
Ingredients DICLOFENAC SODIUM DICLOFENAC SODIUM
Strength(s) 50MG 50MG
Dosage form(s) TABLET (ENTERIC-COATED) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code M01AB M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-12-19 2023-12-19
Estimated end date 2024-02-23 2024-02-23
Actual end date 2024-02-22 2024-02-22
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments